Public Profile

Assertio Holdings, Inc.

Assertio Holdings, Inc., commonly referred to as Assertio, is a prominent biopharmaceutical company headquartered in the United States. Founded in 2013, Assertio has established itself within the specialty pharmaceutical industry, focusing on the development and commercialisation of innovative treatments for pain management and neurology. With a strong operational presence across North America, Assertio is renowned for its unique portfolio of prescription medications, including its flagship product, Zipsor, which offers a novel approach to pain relief. The company has achieved significant milestones, including strategic acquisitions that have bolstered its market position and expanded its therapeutic offerings. Assertio's commitment to improving patient outcomes through targeted therapies underscores its reputation as a leader in the biopharmaceutical sector.

DitchCarbon Score

How does Assertio Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Assertio Holdings, Inc.'s score of 13 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

35%

Assertio Holdings, Inc.'s reported carbon emissions

Assertio Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor Assertio's future disclosures regarding their climate commitments and any potential strategies they may adopt to reduce their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Assertio Holdings, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Assertio Holdings, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Assertio Holdings, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Taking Reduction Action?

Similar Organizations

ADVANZ PHARMA Corp. Limited

GB
Chemicals nec
Updated 9 days ago

Nektar Therapeutics

US
Chemicals nec
Updated 13 days ago

PHH Home Loans, LLC

US
Financial intermediation services, except insurance and pension funding services (65)
Updated about 1 month ago
DitchCarbon Score

Cadence Pharmaceuticals Inc.

US
Health and social work services (85)
Updated about 1 month ago
DitchCarbon Score

INSYS Therapeutics, Inc.

US
Chemicals nec
Updated 13 days ago

Coherus BioSciences, Inc.

US
Health and social work services (85)
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers